Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

184165 Press Releases
DateTitleCompany
17 Oct 17 Cleveland Clinic Joins PierianDx’s Customer Network to Accelerate Precision Medicine PierianDx,
Published by
Business Wire
17 Oct 17 OncBioMune Preparing to Initiate Trials of Novel Therapeutic Ovarian Cancer Vaccine Published by
GlobeNewswire
17 Oct 17 Significant advance in breast cancer care – Cohera Medical, Inc. ® Drain-Free Mastectomy trial reaches full enrollment Published by
GlobeNewswire
17 Oct 17 ABLYNX ANNOUNCES LAUNCH OF PROPOSED GLOBAL OFFERING Published by
GlobeNewswire
17 Oct 17 ProMIS Neurosciences Lead Product Candidate, PMN310, Shows Desired Target Binding Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies for Alzheimer’s Disease Published by
GlobeNewswire
17 Oct 17 Teladoc to Announce Third Quarter 2017 Financial Results Published by
GlobeNewswire
17 Oct 17 Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference Published by
GlobeNewswire
17 Oct 17 RadioMedix Selected for National Cancer Institute’s Investor Initiatives and Presentation at BIO Investor Forum Published by
GlobeNewswire
17 Oct 17 Healthwise and Tencent Announce Partnership Published by
GlobeNewswire
17 Oct 17 Quotient Limited to Report Fiscal Second Quarter 2018 Financial Results and Host Conference Call Published by
GlobeNewswire
17 Oct 17 CV Sciences, Inc. Repays Convertible Debt Published by
GlobeNewswire
17 Oct 17 Cellectar Biosciences Receives Additional Japanese Patent for CLR 131 and CLR 125 for the Treatment of Various Solid Tumors Published by
GlobeNewswire
17 Oct 17 Xenon Pharmaceuticals Announces Initiation of XEN1101 Phase 1 Clinical Trial Published by
GlobeNewswire
17 Oct 17 Celsion Provides Summary of Research and Development Day Held on Thursday, October 12, 2017 Published by
GlobeNewswire
17 Oct 17 Biomerica Reports 1st Quarter Fiscal 2018 Financials Published by
GlobeNewswire
17 Oct 17 Saniona AB: Saniona's Partner Cadent Therapeutics Receives Milestone from Novartis Published by
GlobeNewswire
17 Oct 17 AntriaBio Announces Selection of Lead Oral Plasma Kallikrein Inhibitor Candidates for the Treatment of Diabetic Retinopathy, Diabetic Macular Edema and Hereditary Angioedema Published by
GlobeNewswire
17 Oct 17 PositiveID’s E-N-G Mobile Systems’ Announces Incorporation of Advanced Drone Technology Published by
GlobeNewswire
17 Oct 17 Saniona AB: Saniona's Partner Cadent Therapeutics Receives Milestone from Novartis Saniona AB,
Published by
GlobeNewswire
17 Oct 17 Immuron Ltd. Highlights Market Opportunity Following Recent Studies on Antibiotic Correlation to C. Difficile Infections Published by
GlobeNewswire
17 Oct 17 RavenQuest Announces Core Members of Operational Team Published by
GlobeNewswire
17 Oct 17 Tower One to Acquire Mexican Tower Company With AT&T Master Lease Agreement Published by
GlobeNewswire
17 Oct 17 Aduro Biotech Announces Presentation of Phase 1 Data for LADD-based Immunotherapy at World Conference on Lung Cancer Published by
GlobeNewswire
17 Oct 17 Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company Published by
GlobeNewswire
17 Oct 17 R1 RCM and Phreesia Announce Strategic Partnership to Create a Better Patient Experience across the Continuum of Care Published by
GlobeNewswire
17 Oct 17 ReWalk Robotics Launches Public Offering of Ordinary Shares Published by
GlobeNewswire
17 Oct 17 Incysus Announces FDA Approval of IND Application for a Phase 1 Study of a Gamma-Delta (?d) T Cell Leukemia and Lymphoma Immunotherapy Published by
GlobeNewswire
17 Oct 17 TearLab Corporation Provides Update on U.S. Regulatory Strategy for TearLab Discovery™ System Published by
GlobeNewswire
17 Oct 17 Diffusion Pharmaceuticals Receives Final FDA Protocol Guidance for Phase 3 Clinical Trial with TSC in Patients Newly Diagnosed with Inoperable Glioblastoma Multiforme Published by
GlobeNewswire
17 Oct 17 NexImmune and The Leukemia & Lymphoma Society enter partnership for the development of AIM ACT™ in AML patients Published by
GlobeNewswire
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.